1. EP1116 Integrated pathway analysis identifies a 3-gene signature predicting platinum response and outcome of high grade serous ovarian carcinoma patients. (1st November 2019) Authors: Bignotti, E; Benvenuto, G; Paracchini, L; Zanotti, L; Romani, C; Tognon, G; Calura, E; Vicini, D; Adorni, M; Paderno, MC; Paderno, MC; Bianchi, T; Odicino, F; Sartori, E; Ravaggi, A; D'Incalci, M; Marchini, S; Todeschini, P; Romualdi, C Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A582 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EP814 TGFβ pathway activation is a predictor of progression free and overall survival in advanced high-grade serous ovarian cancer according to the surgical aggressiveness and rate of cytoreduction of different oncologic centers. (1st November 2019) Authors: Ceppi, L; Grassi, T; Romualdi, C; Di Lorenzo, P; Palazzi, S; Biagioli, E; Garbi, A; Paracchini, L; Landoni, F; Aletti, GD; Colombo, N; Fruscio, R; Marchini, S; D'Incalci, M Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A450 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗